Morbidity
cough, diarrhea, fever
The specific hypotheses regarding morbidity are the following:Four to 14-month-old children in villages receiving two- or four-dose AZI regimen have lower prevalence of diarrhea within the last 14 days before MDA than same-aged children living in villages receiving placebo.Four to 14-month-old children in villages receiving two- or four-dose AZI regimen have lower prevalence of fever without cough within the last 14 days before MDA than same-aged children living in villages receiving placebo.Four to 14-month-old children in villages receiving two- or four-dose AZI regimen have lower prevalence of respiratory symptoms within the last 14 days before MDA than same-aged children living in villages receiving placebo.Children in villages receiving two- or four-dose AZI regimen have lower prevalence of any morbidity symptoms within the last 14 days before MDA than same-aged children living in villages receiving placebo.